Valenzuela PL, Carrera-Bastos P, Castillo-García A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20:475–94.

Article  PubMed  Google Scholar 

World Population Prospects: the 2019 Revision [Internet]. United Nations. [cited 2023 Aug 20]. Available from: https://population.un.org/dataportal/home

Nunan E, Wright CL, Semola OA, Subramanian M, Balasubramanian P, Lovern PC, et al. Obesity as a premature aging phenotype — implications for sarcopenic obesity. GeroScience. 2022;44:1393–405.

Article  PubMed  PubMed Central  Google Scholar 

Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, et al. Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies. Cancer Med. 2020;9:7964–78.

Article  PubMed  PubMed Central  Google Scholar 

Kim MS, Kim WJ, Khera AV, Kim JY, Yon DK, Lee SW, et al. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur Heart J. 2021;42:3388–403.

Article  PubMed  PubMed Central  Google Scholar 

Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the american heart association. Circulation. 2021;143:e984-1010.

Article  PubMed  PubMed Central  Google Scholar 

Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol. 2013;2013.

Palmer AK, Jensen MD. Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest. 2022;132(16):e158451. 

Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr. 2014;33:737–48.

Article  PubMed  Google Scholar 

Mancuso P, Bouchard B. The impact of aging on adipose function and adipokine synthesis. Front Endocrinol (Lausanne). 2019;10:137.

Neeland IJ, Ross R, Després J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7:715–25.

Article  PubMed  Google Scholar 

Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol Series A. 2012;67:1140–52.

Article  Google Scholar 

Conley KE, Esselman PC, Jubrias SA, Cress ME, Inglin B, Mogadam C, et al. Ageing, muscle properties and maximal O2 uptake rate in humans. J Physiol. 2000;526:211–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conley KE, Jubrias SA, Esselman PC. Oxidative capacity and ageing in human muscle. J Physiol. 2000;526:203–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nair KS. Aging muscle. Am J Clin Nutr. 2005;81:953–63.

Article  CAS  PubMed  Google Scholar 

Brack AS, Muñoz-Cánoves P. The ins and outs of muscle stem cell aging. Skeletal Muscle. 2016;6:1.

Article  PubMed  PubMed Central  Google Scholar 

Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017;35:200–21.

Article  CAS  PubMed  Google Scholar 

Kim G, Kim JH. Impact of skeletal muscle mass on metabolic health. Endocrinol Metab (Seoul). 2020;35:1–6.

Article  PubMed  Google Scholar 

Bizri IE, Batsis JA. Linking epidemiology and molecular mechanisms in sarcopenic obesity in populations. Proc Nutr Soc. 2020;79:448–56.

Article  Google Scholar 

Kirkman DL, Bohmke N, Billingsley HE, Carbone S. Sarcopenic obesity in heart failure with preserved ejection fraction. Front Endocrinol (Lausanne). 2020;11:558271.

Carbone S, Billingsley HE, Rodriguez-Miguelez P, Kirkman DL, Garten R, Franco RL, et al. Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia. Curr Probl Cardiol. 2020;45:100417.

Article  PubMed  Google Scholar 

Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis Nat Rev Dis Primers. 2019;5:1–18.

Article  Google Scholar 

Lobato NS, Filgueira FP, Akamine EH, Tostes RC, Carvalho MHC, Fortes ZB. Mechanisms of endothelial dysfunction in obesity-associated hypertension. Braz J Med Biol Res. 2012;45:392–400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forman DE, Santanasto AJ, Boudreau R, Harris T, Kanaya AM, Satterfield S, et al. Impact of incident heart failure on body composition over time in the health, aging, and body composition study population. Circ Heart Fail. 2017;10:e003915.

Mirzai S, Eck BL, Chen P-H, Estep JD, Tang WHW. Current approach to the diagnosis of sarcopenia in heart failure: a narrative review on the role of clinical and imaging assessments. Circ Heart Fail. 2022;15:e009322.

Article  PubMed  PubMed Central  Google Scholar 

Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Al Malouf C, et al. Sarcopenia and cardiovascular diseases. Circulation. 2023;147:1534–53.

Article  PubMed  PubMed Central  Google Scholar 

•• Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15:321–35. The first consensus statement for sarcopenic obesity from an international expert panel, launched by ESPEN and EASO, proposing a definition and diagnostic criteria.

Article  PubMed  PubMed Central  Google Scholar 

Gortan Cappellari G, Guillet C, Poggiogalle E, Ballesteros Pomar MD, Batsis JA, Boirie Y, et al. Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in Rome November 2022. Clin Nutr. 2023;42:687–99.

Article  PubMed  Google Scholar 

Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020;68:1410–8.

Article  PubMed  Google Scholar 

• Cawthon PM, Manini T, Patel SM, Newman A, Travison T, Kiel DP, et al. Putative cut-points in sarcopenia components and incident adverse health outcomes: an SDOC analysis. J Am Geriatr Soc. 2020;68:1429–37. Meta-analysis by the Sarcopenia Definitions and Outcomes Consortium demonstrating that functional measures like strength and mobility are more relevant than lean mass alone for predicting adverse health outcomes.

Article  PubMed  PubMed Central  Google Scholar 

Carbone S, Kirkman DL, Garten RS, Rodriguez-Miguelez P, Artero EG, Lee D, et al. Muscular strength and cardiovascular disease: an updated state-of-the-art narrative review. J Cardiopulm Rehabil Prev. 2020;40:302–9.

Article  PubMed  Google Scholar 

Tomlinson DJ, Erskine RM, Morse CI, Winwood K, Onambélé-Pearson G. The impact of obesity on skeletal muscle strength and structure through adolescence to old age. Biogerontology. 2016;17:467–83.

Article  CAS  PubMed  Google Scholar 

Schluessel S, Huemer M-T, Peters A, Drey M, Thorand B. Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022 - Results from the German KORA-Age study. Obes Res Clin Pract. 2023;17:349–52.

Article  PubMed  Google Scholar 

Scott D, Blyth F, Naganathan V, Le Couteur DG, Handelsman DJ, Waite LM, et al. Sarcopenia prevalence and functional outcomes in older men with obesity: comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions. Clin Nutr. 2023;42:1610–8.

Article  PubMed  Google Scholar 

Wood BS, Batchek DJ, Lynch DH, Spangler HB, Gross DC, Petersen CL, Batsis JA. Impact of EASO/ESPEN-defined sarcopenic obesity following a technology-based weight loss intervention. Calcif Tissue Int. 2024;114(1):60–73.

Donini LM, Busetto L, Bauer JM, Bischoff S, Boirie Y, Cederholm T, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2020;39:2368–88.

Article  PubMed  Google Scholar 

• Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy x-ray absorptiometry data from the national health and nutrition examination survey 1999–2004. J Am Geriatr Soc. 2013;61:974–80. Study highlighting the wide variability in prevalence estimates for sarcopenic obesity given the lack of consensus on diagnostic criteria.

Article  PubMed  Google Scholar 

Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr. 2021;40:4633–41.